Back to top

Idexx: Neutral Stance Maintained as Long-Term Outlook Stays Opaque, Target Price Raised to $665

In a report released today, Michael Ryskin from Bank of America Securities maintained a Hold rating on Idexx Laboratories, with a price target of $...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

IDEXX Laboratories, Inc. (IDXX)